Graham P. Allaway
Plus aucun poste en cours
Historique de carrière de Graham P. Allaway
Anciens postes connus de Graham P. Allaway
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| PANACOS PHARMACEUTICALS, INC. | Directeur des opérations | 27/02/2009 | 27/02/2009 |
| Fondateur | 01/12/1992 | 27/02/2009 | |
Panacos Pharmaceuticals, Inc. /Old/
 Panacos Pharmaceuticals, Inc. /Old/ Miscellaneous Commercial ServicesCommercial Services Panacos Pharmaceuticals is engaged in the discovery and development of small molecule oral drugs for the treatment of HIV and other major human viral diseases. Panacos’ proprietary discovery technologies focus on novel targets in the virus life cycle, including virus fusion and virus maturation, the first and last steps of viral infection | Directeur des opérations | 03/03/2005 | 03/03/2005 |
| President | - | 03/03/2005 | |
Manchester Biotech
 Manchester Biotech BiotechnologyHealth Technology Manchester Biotech is an American biotechnology company. | President | 01/01/1997 | 01/01/1998 |
| PRESSURE BIOSCIENCES, INC. | Corporate Officer/Principal | 26/11/2009 | - |
Formation de Graham P. Allaway
| University of Oxford | Graduate Degree |
| University of London | Doctorate Degree |
Statistiques
Internationale
| Etats-Unis | 5 |
| Royaume-Uni | 3 |
Opérationnelle
| President | 2 |
| Chief Operating Officer | 2 |
| Graduate Degree | 1 |
Sectorielle
| Health Technology | 4 |
| Consumer Services | 3 |
| Commercial Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| PRESSURE BIOSCIENCES, INC. | Health Technology |
| PANACOS PHARMACEUTICALS, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Manchester Biotech
Manchester Biotech BiotechnologyHealth Technology Manchester Biotech is an American biotechnology company. | Health Technology |
Panacos Pharmaceuticals, Inc. /Old/
Panacos Pharmaceuticals, Inc. /Old/ Miscellaneous Commercial ServicesCommercial Services Panacos Pharmaceuticals is engaged in the discovery and development of small molecule oral drugs for the treatment of HIV and other major human viral diseases. Panacos’ proprietary discovery technologies focus on novel targets in the virus life cycle, including virus fusion and virus maturation, the first and last steps of viral infection | Commercial Services |
- Bourse
- Insiders
- Graham P. Allaway
- Expérience
